Search Results 211-220 of 14852 for alt

1. A Study to Evaluate the Impact on NASH with Fibrosis of Obeticholic Acid Treatment - Mayo Clinic

   ALT > 1.5 × upper limit of normal (ULN). For subjects with a historical biopsy, is either not taking or is on stable doses of TZDs/glitazones or vitamin E ...

2. Study to Assess the Safety, Tolerability, Efficacy and PK of APL-2 in Patients With wAIHA or CAD - Mayo Clinic

   Abnormal liver function as indicated by elevated AST or ALT. Any elevation of AST or ALT level >2x upper limit of normal (ULN) will require Sponsor review and ...

3. Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors - Mayo Clinic

   Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =< 3.0 x ULN. No known central nervous system metastases unless adequately treated, stable ...

4. CardiolRx In Recurrent Pericarditis Following IL-1 Blocker Cessation - Mayo Clinic

   Elevated alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \> 5 times the upper limit of normal (ULN) or ALT or AST \> 3x ULN plus ...

5. A Study of Lacosamide to Treat Neonatal Seizures - Mayo Clinic

   ... (ALT), and alkaline phosphatase (ALP), with the following exception: For participants with perinatal asphyxia, elevation of AST, ALT, or ALP 2mg/dL.

6. TheraSphere With and Without Durvalumab and Tremelimumab for HCC - Mayo Clinic

   ... ALT should be ≤3xULN and for treated patients, antiviral treatment (per local standard of care) should be stopped for a minimum of 14 days prior to study ...

7. A Study to Evaluate Non-invasive Biomarkers of Metabolic Liver Disease - Mayo Clinic

   Abnormal ALT (> 30 U/L for men, > 19 U/L for women) without other common causes such as HCV, HBV AND meets criteria within 36 months for ATP III criteria ...

8. Liver transplant - Doctors & Departments - Mayo Clinic

   Joo DJ, et al. Bioartificial liver support for acute liver failure. Annals of Liver Transplantation. 2025; doi:10.52604/alt.25.0004. Taner T, et al. Summary of ...

9. Momelotinib Versus Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

   Platelet Count ≥ 50 x 10^9/L (≥ 100 x 10^9/L if aspartate aminotransferase [AST] or alanine aminotransferase [ALT] is ≥ 2 x the upper limit of the normal ...

10. A Study Comparing a Vaccine with or without an Autologous Tumor Lysate to Treat Stage III or IV Melanoma to Prevent Recurrence - Mayo Clinic

    ALT and AST ≤ 1.5 ULN. For women of child-bearing potential, agreement to use adequate birth control (abstinence, hysterectomy, bilateral oophorectomy ...